UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
 
 Form 6-K
 
 
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
 
For February 2019

Commission File No. 001-36848
 
 
Check-Cap Ltd.
____________________________________________________________________________________________
 
Check-Cap Building
Abba Hushi Avenue
P.O. Box 1271
Isfiya, 30090
Mount Carmel, Israel
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES.)
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
 
Form 20-F ☒ Form 40-F ☐
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____

This Form 6-K is being incorporated by reference into the Post-Effective Amendment No. 1 to the Form S-8 Registration Statement File No. 333-203384, Form S-8 Registration Statement File No. 333-226490, and into the Form F-3 Registration Statements File Nos. 333-211065 and 333-225789.
 


Other Information
 
On February 12, 2019, Check-Cap Ltd. issued a press release announcing it received Institutional Review Board (IRB) approval from the New York University School of Medicine to initiate a U.S. pilot study of the C-Scan® system.
 
A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.   
 
Exhibit
 
 
 
 
 
Exhibit No. 
 
Description
 
 
 



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 
Check-Cap Ltd.
 
 
 
By:
/s/ Alex Ovadia
 
 
Name: Alex Ovadia
 Date: February 12, 2019
 
Title: Chief Executive Officer